
Supreme Court Grapples With Discrimination Lawsuit Against Labcorp
The Supreme Court struggled this week with a complex discrimination lawsuit that blind patients filed against Labcorp over self-service kiosks they could not use.
The case, Laboratory Corporation of America Holdings v. Davis, was heard on April 29.
The petitioner does business with the public as Labcorp. The respondents are blind Labcorp patients, including Luke Davis and Julian Vargas.
The issue in the case is whether a federal district court may certify a class action that includes claimants who have not experienced an injury.
In a class action, one or more plaintiffs sue on behalf of a 'class,' or a larger group of people who claim to have suffered the same injury because of a defendant. Federal and state court rules govern whether a class action gets certified and is allowed to proceed.
The case goes back to 2017, when Labcorp, a major provider of diagnostic services, offered patients a new way to check in for appointments, according to the company's
Related Stories
1/27/2025
6/8/2023
The company began offering self-service kiosks at its patient service centers, but blind individuals could not access them without help, the petition said.
In 2020, a group of legally blind people filed a putative—or proposed—class action lawsuit, claiming that the kiosks violated the federal Americans with Disabilities Act (ADA) and California's Unruh Civil Rights Act.
Labcorp claims that not all blind people in the class actually experienced injuries as a result of the company's policies.
When it granted the petition on Jan. 24, the Supreme Court said it would consider whether federal civil procedure rules allow a federal court to certify a class action 'when some members of the proposed class lack any Article III injury.'
Article III of the U.S. Constitution governs federal courts and has been interpreted as saying that those courts may only hear cases involving actual controversies in which at least one litigant has standing to sue.
Standing refers to the right of someone to sue in court. The parties must show a strong enough connection to the claim to justify their participation in a lawsuit.
The company stated in the petition that 'it is very hard to find blind patients actually harmed by the availability of Labcorp's new kiosks.'
Many blind patients 'either do not know these kiosks exist or, if they did, have zero interest in using them, preferring instead to use the front-desk option that has served them well for years,' it said.
Moreover, the other side could not point to any patients who could not avail themselves of Labcorp's services because they could not access a kiosk, according to the petition.
The plaintiffs in the original lawsuit defined the proposed classes as 'all blind patients who had been merely exposed to these allegedly unlawful kiosks—i.e., blind patients who had walked into a [patient service center] with a kiosk, regardless of whether they knew about or wanted to use it.'
The plaintiffs said this meant the classes could number as many as hundreds of thousands of people and could lead to about half a billion dollars per year in damages, the petition states.
In May 2022, a federal district court certified two classes in the lawsuit.
One class consisted of patients in California seeking damages under the Unruh Act; the other class consisted of patients across the country seeking relief under the ADA and two other federal statutes—the Rehabilitation Act and the Patient Protection and Affordable Care Act.
Labcorp appealed the class certifications to the U.S. Court of Appeals for the Ninth Circuit, which sided with the patients in a February 2024
'Neither court ... disputed that each class contained a sizable number of members who lacked Article III injuries—which makes good sense, because a person simply proximate to an allegedly unlawful kiosk has not suffered any concrete injury,' the petition said.
The Ninth Circuit's 'lax approach to certification' has been rejected by about half the federal circuit courts, it added.
Allowing uninjured persons into a class 'can drive up potential liability, and thus manufacture leverage with which to extort a settlement.' This means that weak claims can move forward and millions of dollars can be 'extracted from companies who have done nothing wrong—but nonetheless cannot tolerate a massive litigation risk,' the petition said.
During the April 29 oral
'If a class is defined to include plaintiffs without Article III standing and, as a result, you need thousands of mini-trials to separate the wheat from the chaff, the Article III issue necessarily swamps any common ones,' said Francisco, who was U.S. solicitor general for most of the first Trump administration.
In this case, 'plaintiffs who don't want to use kiosks don't have standing to challenge how kiosks work any more than a vegan has standing to challenge how a restaurant defines a medium rare steak,' he said.
It follows that the Supreme Court 'needs to assess whether each of the 8,000 to 112,000 class members actually want to use kiosks, and that will necessarily swamp any common issues, as the D.C. and First Circuits correctly held' in two prior cases, Francisco said.
Justice Clarence Thomas asked Francisco if the Supreme Court has jurisdiction to deal with this case.
'This court has the jurisdiction to address that judgment, reverse it, and send it back to the Ninth Circuit,' the attorney said.
Justice Ketanji Brown Jackson said Labcorp is responsible 'for the confusion that we are in right now.'
She said Labcorp previously argued that the class definition was 'too narrow' but that today, it is 'saying it's improper because it's too broad.' The definition 'now includes uninjured people, whereas, before, it … contained only injured people,' she said.
Justice Sonia Sotomayor expressed concern that the Ninth Circuit's opinion may be an advisory opinion.
An advisory opinion is a non-binding opinion in which a court provides advice on a hypothetical legal question.
The Supreme Court has long held that Article III of the U.S. Constitution, which gives federal courts jurisdiction, or authority, over live disputes,
During a discussion with Department of Justice attorney Sopan Joshi, Justice Neil Gorsuch said the Ninth Circuit ruling 'really does start to sound sort of like an advisory [opinion].'
The respondents' attorney, Deepak Gupta, said the Supreme Court has previously ruled that 'Article III doesn't give federal courts the power to give relief to any uninjured plaintiff, class action or not.'
The lawyer said if the court rules on the merits of the case and issues an 'advisory opinion,' that opinion should state 'that at the class certification stage, the proper inquiry is whether there will be an administratively feasible mechanism to weed out the uninjured.'
The Supreme Court is expected to rule on the case by the end of June.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, will showcase inhaled insulin at the American Diabetes Association's (ADA) 85th Scientific Sessions from June 20-23 in Chicago. Dr. Michael J. Haller, Professor and Chief of Pediatric Endocrinology at the University of Florida, will present the results from the randomized period of the INHALE-1 clinical trial during a 'Future Ready' symposium. Dr. Haller is the Chair for MannKind's Phase 3 INHALE-1 study of Afrezza (insulin human) Inhalation Powder in children and adolescents (aged 4-17 years of age). The presentation/posters planned at ADA's 85th Scientific Sessions regarding the most recent advances in inhaled insulin treatment include: Symposium – Future Ready – Breakthrough in Pediatric Type 1 Diabetes Care Sunday, June 22 – 1:30 to 3:00 p.m. (Central) in Room W 181(A-C)Dr. Michael J. Haller will present: From Discovery to Treatment – Latest Updates on Inhaled Insulin Treatment Patient Reported Outcomes with Use of Inhaled Technosphere Insulin (T1) (Board 827)Saturday, June 21, 2025 – 12:30 to 1:30 p.m. (Central) Presenter: Dr. Peter Calhoun Efficacy and Safety of Prandial Technosphere Inhaled Insulin (Afrezza) Compared with Placebo in Adult Individuals with T2DM – Results from a Phase III Clinical Trial from India (Board No. 833)Saturday, June 21, 2025 – 12:30 to 1:30 p.m. (Central) Presenter: Dr. K M Prasanna Kumar Additionally, MannKind will host booth #1617 in the Exhibit Hall throughout the ADA's Scientific Sessions. Members of MannKind's Medical Education Team will be available for scientific exchange in the medical section of the booth. For more information about ADA's Scientific Sessions programming, and/or to register to attend the conference, please visit: MannKind expects to issue the topline results from the full study pediatric data set with safety extension in 2Q 2025 and anticipates submitting a Supplemental Biologics License Application in mid-2025 for a potential pediatric indication for Afrezza. About MannKindMannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease, pulmonary fibrosis, and pulmonary hypertension. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication. With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life. Please visit to learn more, and follow us on LinkedIn, Facebook, X or Instagram. Forward-Looking StatementsThis press release contains forward-looking statements about a planned release of scientific data and a potential sBLA submission for Afrezza that involves risks and uncertainties. Words such as 'believes', 'anticipates', 'plans', 'expects', 'intends', 'will', 'goal', 'potential' and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon MannKind's current expectations. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, the risk that issues that develop in the preparation of data releases and filings may subject us to unanticipated delays as well as other risks detailed in MannKind's filings with the Securities and Exchange Commission, including under the 'Risk Factors' heading of its Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent periodic reports on Form 10-Q and current reports on Form 8-K. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and MannKind undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release. AFREZZA and MANNKIND are registered trademarks of MannKind Corporation. CONTACT: MannKind Contacts: Media Relations Christie Iacangelo, (818) 292-3500 Email: media@ Investor Relations Ana Kapor, (818) 661-5000 Email: ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Walton County to break ground on Driftwood Road
WALTON COUNTY, Fla. (WMBB) – The Walton County Board of County Commissioners and the Walton County Beach Operations and Tourism Departments plan to break ground on the Driftwood Road Municipal Parking facility. According to a news release, the construction will begin Monday, June 16, on 76 Driftwood Road in Miramar Beach at 9 a.m. U.S. 231 Road Improvement Project to begin in Bay County Walton County's need for public beach access, rest areas and transit stops led to the project approval from the BCC. The Driftwood Road Municipal Parking facility will include 67 parking spaces with dedicated ADA, LSV and bicycle parking. Four of the parking spots will also include electric vehicle charging stations. Officials say the construction of the 1.119-acre lot will take approximately 11 months. For visitors, the public transit stop will have air-conditioning as well as a restroom facility for convenience. The Tourist Development Tax, a 5% tax collected on short-term rentals in south Walton County, funds this development. For more information and project updates, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


CNET
9 hours ago
- CNET
CNET's Tariff Price Tracker: What I've Found Watching 11 Key Products for Changes
A trade court has ruled Trump's tariff barrage illegal, but the possibility that prices could climb remains real. James Martin/CNET I've been keeping tabs on several popular products on a daily basis for CNET's tariff impact tracker, watching for price hikes amid President Donald Trump's import tax agenda. Most prices I've been looking at have remained stable so far, aside from notable increases for the Xbox Series X and a budget-friendly 4K TV, and the occasional discounts during big sale periods, which is currently the case for some popular earbuds and an affordable soundbar. With all that said, the broader impacts of these import taxes are still on the horizon, unless a trade court ruling against them gets to stay in place. The Trump administration has, unsurprisingly, decried this ruling -- which said Trump had no authority to set tariffs as he has been -- and moved swiftly to request that the Supreme Court strike it down. We'll see how that ultimately plays out but, for now, the possibility that the president's tariff policies will lead to price hikes remains likely. That's why I'm continuing to monitor several key products you might want or need to buy soon, to keep track of the potential tariff impacts. CNET Tariff Tracker Index Above, you can check out a chart with the average price of the 11 products included in this piece over the course of 2025. This will help give you a sense of the overall price changes and fluctuations going on. Further down, you'll be able to check out charts for each individual product being tracked. We'll be updating this article regularly as prices change. It's all in the name of helping you make sense of things so be sure to check back every so often. For more, check out CNET's guide to whether you should wait to make big purchases or buy them now and get expert tips about how to prepare for a recession. Now Playing: Should You Buy Now or Wait? Our Experts Weigh In on Tariffs 09:42 Methodology We're checking prices daily and will update the article and the relevant charts right away to reflect any changes. The following charts show a single bullet point for each month, with the most recent one labeled "Now" and showing the current price. For the past months, we've gone with what was the most common price for each item in the given month. In most cases, the price stats used in these graphs were pulled from Amazon using the historical price-tracker tool Keepa. For the iPhones, the prices come from Apple's official materials and are based on the 128-gigabyte base model of the latest offering for each year: the iPhone 14, iPhone 15 and iPhone 16. For the Xbox Series X, the prices were sourced from Best Buy using the tool PriceTracker. If any of these products happen to be on sale at a given time, we'll be sure to let you know and explain how those price drops differ from longer-term pricing trends that tariffs can cause. The 11 products we're tracking Mostly what we're tracking in this article are electronic devices and digital items that CNET covers in depth, like iPhones and affordable 4K TVs -- along with a typical bag of coffee, a more humble product that isn't produced in the US to any significant degree. The products featured were chosen for a few reasons: Some of them are popular and/or affordable representatives for major consumer tech categories, like smartphones, TVs and game consoles. Others are meant to represent things that consumers might buy more frequently, like printer ink or coffee beans. Some products were chosen over others because they are likely more susceptible to tariffs. Some of these products have been reviewed by CNET or have been featured in some of our best lists. Below, we'll get into more about each individual product, and stick around till the end for a rundown of some other products worth noting. iPhone 16 The iPhone is the most popular smartphone brand in the US, so this was a clear priority for price tracking. The iPhone has also emerged as a major focal point for conversations about tariffs, given its popularity and its susceptibility to import taxes because of its overseas production, largely in China. Trump has reportedly been fixated on the idea that the iPhone can and should be manufactured in the US, an idea that experts have dismissed as a fantasy. Estimates have also suggested that a US-made iPhone would cost as much as $3,500. Something to note about this graph: The price listed is the one you'll see if you buy your phone through a major carrier. If you, say, buy direct from Apple or Best Buy without a carrier involved, you'll be charged an extra $30, so in some places, you might see the list price of the standard iPhone 16 listed as $830. Apple's been taking a few steps to protect its prices in the face of these tariffs, flying in bulk shipments of product before they took effect and planning to move production for the US market from China to India. This latter move drew the anger of Trump again, threatening the company with a 25% tariff if they didn't move production to the US, an idea CEO Tim Cook has repeatedly shot down in the past. This came after Trump gave a tariff exemption to electronic devices including smartphones, so the future of that move seems in doubt now. Apple's flagship device is still the top-selling smartphone globally, as of Q1 of this year, although new research from the firm Counterpoint suggests that tariff uncertainty will cause the brand's growth to stall a bit throughout the rest of 2025. Duracell AA batteries A lot of the tech products in your home might boast a rechargeable energy source but individual batteries are still an everyday essential and I can tell you from experience that as soon as you forget about them, you'll be needing to restock. The Duracell AAs we're tracking are some of the bestselling batteries on Amazon. Samsung DU7200 TV Alongside smartphones, televisions are some of the most popular tech products out there, even if they're an infrequent purchase. This particular product is a popular entry-level 4K TV and was CNET's pick for best overall budget TV for 2025. Unlike a lot of tech products that have key supply lines in China, Samsung is a South Korean company so it might have some measure of tariff resistance. Xbox Series X Video game software and hardware are a market segment expected to be hit hard by the Trump tariffs. Microsoft's Xbox is the first console brand to see price hikes -- the company cited "market conditions" along with the rising cost of development. Most notably, this included an increase in the price of the flagship Xbox Series X, up from $500 to $600. Numerous Xbox accessories also were affected and the company also said that "certain" games will eventually see a price hike from $70 to $80. Initially, we were tracking the price of the much more popular Nintendo Switch as a representative of the gaming market. Nintendo has not yet hiked the price of its handheld-console hybrid and stressed that the $450 price tag of the upcoming Switch 2 has not yet been inflated because of tariffs. Sony, meanwhile, has so far only increased prices on its PlayStation hardware in markets outside the US. AirPods Pro 2 The latest iteration of Apple's wildly popular true-wireless earbuds are here to represent the headphone market. Much to the chagrin of the audiophiles out there, a quick look at sales charts on Amazon shows you just how much the brand dominates all headphone sales. Earlier in the year, they tended to hover around $199 on the site, a notable discount from its $249 list price, but the price is currently the much more enticing $169, so move fast if you want an affordable pair. (Or maybe just wait for the rumored AirPods Pro 3.) HP 962 CMY printer ink This HP printer ink includes cyan, magenta and yellow all in one product and recently saw its price jump from around $72 -- where it stayed for most of 2025 -- to $80, which is around its highest price over the last five years. We will be keeping tabs to see if this is a long-term change or a brief uptick. This product replaced Overture PLA Filament for 3D printers in this piece, but we're still tracking that item. Anker 10,000-mAh, 30-watt power bank Anker's accessories are perennially popular in the tech space and the company has already announced that some of its products will get more expensive as a direct result of tariffs. This specific product has also been featured in some of CNET's lists of the best portable chargers. While the price has remained steady throughout the year, it is currently on sale for $13, or 50% off, for a limited time. Bose TV speaker Soundbars have become important purchases, given the often iffy quality of the speakers built into TVs. While not the biggest or the best offering in the space, the Bose TV Speaker is one of the more affordable soundbar options out there, especially hailing from a brand as popular as Bose. This product has been one of the steadiest on this list in terms of price throughout the year, but it's currently on sale for $199, potentially as part of Amazon's Memorial Day sale. So, if you're looking for an affordable, tariff-free TV speaker, now might be the time. Oral-B Pro 1000 electric toothbrush They might be a lot more expensive than their traditional counterparts but electric toothbrushes remain a popular choice for consumers because of how well they get the job done. I know my dentist won't let up on how much I need one. This particular Oral-B offering was CNET's overall choice for the best electric toothbrush for 2025. Lenovo IdeaPad Flex 5i Chromebook Lenovo is notable among the big laptop manufacturers for being a Chinese company making its products especially susceptible to Trump's tariffs. Starbucks Ground Coffee (28-ounce bag) Coffee is included in this tracker because of its ubiquity -- I'm certainly drinking too much of it these days -- and because it's uniquely susceptible to Trump's tariff agenda. Famously, coffee beans can only be grown within a certain distance from Earth's equator, a tropical span largely outside the US and known as the "Coffee Belt." Hawaii is the only part of the US that can produce coffee beans, with data from USAFacts showing that 11.5 million pounds were harvested there in the 2022-23 season -- little more than a drop in the mug, as the US consumed 282 times that amount of coffee during that period. Making matters worse, Hawaiian coffee production has declined in the past few years. All that to say: Americans get almost all of their coffee from overseas, making it one of the most likely products to see price hikes from tariffs. Other products As mentioned before, we occasionally swap out products with different ones that undergo notable price shifts. Here are some things no longer featured above, but that we're still keeping an eye on: Nintendo Switch: The baseline handheld-console hybrid has held steady around $299 most places -- including Amazon impending release of the Switch 2 remains to be seen. This product was replaced above with the Xbox Series X. impending release of the Switch 2 remains to be seen. This product was replaced above with the Xbox Series X. Overture PLA 3D printer filament: This is a popular choice on Amazon Here are some products we also wanted to single out that haven't been featured with a graph yet: Razer Blade 18 (2025), 5070 Ti edition: The latest revision of Razer's largest gaming laptop saw a $300 price bump recently, with the base model featured an RTX 5070 Ti graphics card now priced at $3,500 ahead of launch, compared to the $3,200 price announced in February. While Razer has stayed mum about the reasoning, it did previously suspend direct sales to the US as Trump's tariff plans were ramping up in April. Asus ROG Ally X: The premium version of Asus's Steam Deck competitor handheld gaming PC recently saw a price hike from $799 to $899, coinciding with the announcement of the company's upcoming Xbox-branded Ally handhelds.